Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)

HKG:8189 Revenue

Tianjin TEDA Biomedical Engineering Company had revenue of 296.03M CNY in the half year ending June 30, 2026, with 39.92% growth. This brings the company's revenue in the last twelve months to 592.59M, up 50.83% year-over-year. In the year 2025, Tianjin TEDA Biomedical Engineering Company had annual revenue of 522.97M with 35.67% growth. That makes Tianjin TEDA Biomedical Engineering Company the world's 23,694th largest company by revenue and 1,409th in Hong Kong.

• Revenue (ttm): 592.59M CNY
• Revenue Growth: +50.83%
• P/S Ratio: 0.78
• Revenue / Employee: 2.17M CNY
• Employees: 273
• Market Cap: 514.27M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	522.97M	137.48M	35.67%
Dec 31, 2024	385.48M	-12.52M	-3.14%
Dec 31, 2023	398.00M	-5.73M	-1.42%
Dec 31, 2022	403.73M	-72.66M	-15.25%
Dec 31, 2021	476.38M	107.03M	28.98%

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 6, 2026

Data Sources Report a data error